Plus   Neg

Accor 2018 EBITDA In Line With Group's Guidance; LFL Revenue Up 8.8%

Accor (ACRFY.PK,ACRFF.PK) reported that its fiscal 2018 EBITDA increased 14.5% to 712 million euros from last year, or up 8.0% like-for-like, in line with the Group's guidance of between 700 million euros and 720 million euros. The EBITDA margin was roughly stable on a like-for-like basis at 19.7%. The sale of 65% of the capital of AccorInvest and its deconsolidation from Accor' financial statements resulted in a 2.4 billion euros capital gain, bringing net profit, Group share to 2.23 billion euros in 2018.

Consolidated 2018 revenue amounted to 3.61 billion euros, up 8.8% at constant scope of consolidation and exchange rates (like-for-like) and up 16.9% as reported compared with 2017. The Group said the difference between the like-for-like and reported changes stems primarily from the acquisitions completed over the year (including Mantra and Mövenpick), partly offset by a negative currency effect.

HotelServices reported business volume was 20 billion euros, up 13.4% at constant exchange rates, and revenue of 2.62 billion euros, up 8.4% like-for-like, for the period. Reported revenue growth amounted to 5.4%, impacted by a negative currency effect.

Accor' Board of Directors will ask shareholders at the General Meeting of April 30, 2019 to approve the payment of a dividend of 1.05 euros per share.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Billionaire Warren Buffett's Berkshire Hathaway reported a profit for the second-quarter that increased 87 percent from last year, as the value of its investment portfolio increased with the stock market. But it took about $10 billion write down on the value of its Precision Castparts aircraft parts unit due to the impact of the COVID-19 pandemic. Operating profit declined 10 percent. Twitter has had preliminary talks with TikTok's Chinese owner ByteDance to buy the U.S. operations of the video-sharing app, the Wall Street Journal reported citing people familiar with the matter. Meanwhile, Microsoft has been the only company so far to say publicly it is pursuing TikTok. Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients.
Follow RTT